1. Home
  2. SCLXW vs NAKAW Comparison

SCLXW vs NAKAW Comparison

Compare SCLXW & NAKAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLXW
  • NAKAW
  • Stock Information
  • Founded
  • SCLXW N/A
  • NAKAW N/A
  • Country
  • SCLXW United States
  • NAKAW United States
  • Employees
  • SCLXW 111
  • NAKAW 61
  • Industry
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • NAKAW
  • Sector
  • SCLXW Health Care
  • NAKAW
  • Exchange
  • SCLXW Nasdaq
  • NAKAW Nasdaq
  • Market Cap
  • SCLXW N/A
  • NAKAW N/A
  • IPO Year
  • SCLXW N/A
  • NAKAW 2024
  • Fundamental
  • Price
  • SCLXW $0.10
  • NAKAW $8.01
  • Analyst Decision
  • SCLXW
  • NAKAW
  • Analyst Count
  • SCLXW 0
  • NAKAW 0
  • Target Price
  • SCLXW N/A
  • NAKAW N/A
  • AVG Volume (30 Days)
  • SCLXW 4.0K
  • NAKAW N/A
  • Earning Date
  • SCLXW 03-07-2025
  • NAKAW N/A
  • Dividend Yield
  • SCLXW N/A
  • NAKAW N/A
  • EPS Growth
  • SCLXW N/A
  • NAKAW N/A
  • EPS
  • SCLXW N/A
  • NAKAW N/A
  • Revenue
  • SCLXW $55,152,000.00
  • NAKAW N/A
  • Revenue This Year
  • SCLXW N/A
  • NAKAW N/A
  • Revenue Next Year
  • SCLXW N/A
  • NAKAW N/A
  • P/E Ratio
  • SCLXW N/A
  • NAKAW N/A
  • Revenue Growth
  • SCLXW 22.02
  • NAKAW N/A
  • 52 Week Low
  • SCLXW $0.18
  • NAKAW N/A
  • 52 Week High
  • SCLXW $0.18
  • NAKAW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SCLXW N/A
  • NAKAW N/A
  • Support Level
  • SCLXW N/A
  • NAKAW N/A
  • Resistance Level
  • SCLXW N/A
  • NAKAW N/A
  • Average True Range (ATR)
  • SCLXW 0.00
  • NAKAW 0.00
  • MACD
  • SCLXW 0.00
  • NAKAW 0.00
  • Stochastic Oscillator
  • SCLXW 0.00
  • NAKAW 0.00

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About NAKAW Kindly MD Inc. Warrants

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Share on Social Networks: